Department of Obsterics and Gynecology, Faculty of Medicine, Minia University, Minia, Egypt.
Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt.
J Ovarian Res. 2021 Apr 1;14(1):52. doi: 10.1186/s13048-021-00800-5.
The clinical implication of the increased serum progesterone level on the day of HCG administration in assisted reproduction treatment (ART) is still controversial. The current study aimed to compare the predictive value of serum progesterone on day of HCG administration / metaphase II oocyte (P/MII) ratio on IVF/ ICSI outcome to serum progesterone (P) level alone and the ratio of serum progesterone/estradiol level (P/E2) ratio in prediction of pregnancy rates after ART.
MATERIAL & METHODS: Two hundred patients admitted to the IVF/ICSI program at Minia IVF center in Egypt in the period from October 2016 to May 2018 were included in this study. Serum Progesterone (P) and Estradiol (E2) levels were estimated on the day of HCG administration. The ratio between serum P and the number of MII oocytes (P/MII ratio) was calculated and the predictive values of the three parameters (P, P/E2 ratio and P/MII ratio) in prediction of cycle outcomes were measured.
P/ MII oocyte ratio was significantly lower in patients who attained clinical pregnancy (n = 97) as compared with those who couldn't whilst there was no significant difference in P and P/E2 ratio between the two groups. Using a cut off value of 0.125, the sensitivity and specificity of progesterone/ MII ratio in prediction of no pregnancy in IVF/ICSI were 75.7 and 77.1% respectively with the area under The Receiver operating curve (ROC-AUC) = 0.808. The respective values of the ROC-AUC for the P and P/E2 ratio were 0.651 and 0.712 with sensitivity and specificity of 71.2 and 73.5%for P level and of 72.5 and 75.3% for P/E2 ratio. Implantation or clinical pregnancy rates were significantly different between patients with high and low P/MII ratio irrespective of day of embryo transfer (day 3 or 5).
In patients with normal ovarian response, serum progesterone on day of HCG / MII oocyte ratio can be a useful predictor of pregnancy outcomes and in deciding on freezing of all embryos for later transfer instead of high progesterone level alone.
在辅助生殖治疗(ART)中,HCG 给药日血清孕酮水平升高的临床意义仍存在争议。本研究旨在比较血清孕酮在 HCG 给药日/中期 II 卵母细胞(P/MII)比值(P/MII 比值)对 IVF/ICSI 结局的预测价值与血清孕酮(P)水平单独以及血清孕酮/雌二醇比值(P/E2 比值)对 ART 后妊娠率的预测价值。
本研究纳入了 2016 年 10 月至 2018 年 5 月在埃及米尼亚 IVF 中心接受 IVF/ICSI 治疗的 200 例患者。在 HCG 给药日测定血清孕酮(P)和雌二醇(E2)水平。计算血清 P 与 MII 卵母细胞数的比值(P/MII 比值),并测量这三个参数(P、P/E2 比值和 P/MII 比值)在预测周期结局方面的预测价值。
与未妊娠组相比,临床妊娠组(n=97)的 P/MII 比值显著降低,而两组间 P 和 P/E2 比值无显著差异。使用 0.125 的截断值,孕酮/ MII 比值预测 IVF/ICSI 无妊娠的灵敏度和特异性分别为 75.7%和 77.1%,受试者工作特征曲线(ROC-AUC)下面积(AUC)为 0.808。P 和 P/E2 比值的 ROC-AUC 值分别为 0.651 和 0.712,P 水平的灵敏度和特异性分别为 71.2%和 73.5%,P/E2 比值的灵敏度和特异性分别为 72.5%和 75.3%。无论胚胎移植日(第 3 天或第 5 天)如何,高 P/MII 比值和低 P/MII 比值的患者之间的种植率或临床妊娠率均有显著差异。
在卵巢反应正常的患者中,HCG 给药日血清孕酮/MII 卵母细胞比值可作为预测妊娠结局的有用指标,并决定是否冷冻所有胚胎以备日后移植,而不仅仅是孕酮水平升高。